Tekla Capital Management’s Quest Diagnostics DGX Stock Holding History

Tekla Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-109,659	Closed	-$13.1M	–	204
2020 Q4	$13.1M	Hold	109,659	–	–	0.46%	66
2020 Q3	$12.6M	Buy	109,659 +88,634	+422%	+$10.5M	0.47%	56
2020 Q2	$2.4M	Hold	21,025	–	–	0.09%	153
2020 Q1	$1.69M	Hold	21,025	–	–	0.08%	145
2019 Q4	$2.25M	Sell	21,025 -4,987	-19%	-$520K	0.08%	148
2019 Q3	$2.78M	Hold	26,012	–	–	0.12%	117
2019 Q2	$2.65M	Sell	26,012 -40,488	-61%	-$3.89M	0.11%	121
2019 Q1	$5.98M	Hold	66,500	–	–	0.24%	87
2018 Q4	$5.54M	Buy	66,500 +27,500	+71%	+$2.58M	0.24%	81
2018 Q3	$4.21M	Buy	+39,000	New	+$4.28M	0.15%	103

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Tekla Capital Management's DGX Position: Q1 2021 in Review

Tekla Capital Management sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 109,659 shares — an estimated $13.1M sold.

Tekla Capital Management first reported a position in DGX in Q3 2018 and held it in 10 quarters. The position peaked at $13.1M in Q4 2020. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

Tekla Capital Management reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
Tekla Capital Management sold 109,659 Quest Diagnostics shares in Q1 2021, an estimated $13.1M.
Tekla Capital Management first reported a position in Quest Diagnostics in Q3 2018 and held it in 10 quarters.
Tekla Capital Management's Quest Diagnostics position peaked at $13.1M in Q4 2020.
817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Tekla Capital Management's 13F filing for Q1 2021, filed 14 May 2021.